diff options
| author | mac <ra@afu.re> | 2025-11-25 09:00:59 -0500 |
|---|---|---|
| committer | mac <ra@afu.re> | 2025-11-25 09:00:59 -0500 |
| commit | 45272999c6c4bcfcc08aeaf03908e36be5db7570 (patch) | |
| tree | bf7d879eec9c714994277a39dc938e0db2340aa8 | |
| parent | 5abe0f18274b0ea87c0413f1e04fc3721b8cd25d (diff) | |
Auto from mac asahi - Tue 25 Nov 2025 09:00:59 AM EST
| -rw-r--r-- | Finance/Tickers/CRMD.md | 23 | ||||
| -rw-r--r-- | Finance/Tickers/index.md | 2 | ||||
| -rw-r--r-- | Finance/index.md | 12 |
3 files changed, 36 insertions, 1 deletions
diff --git a/Finance/Tickers/CRMD.md b/Finance/Tickers/CRMD.md new file mode 100644 index 0000000..139b726 --- /dev/null +++ b/Finance/Tickers/CRMD.md @@ -0,0 +1,23 @@ +# CorMedix inc. - NASDAQ:CRMD + +Story parrallel to suganmadex introduction + +Taurolock & Taurolidine + +Solving CRBST (catherer blood stream infection) + +CRMD instead of using Citrate develloped their own solution. +Pairing Taurolidine with heparin making DefenCath +DefenCath FDA approved in Nov 2023 +Target: Hospitals & dyalisis clinics + +Total Market potential more or less ~170,000 patient +now around ~3000 patient +already signed contracts for 70% TAM (?) + +looking at end 2027$ + +~250$ per vial +CRBST cost around 63,000$ per case, nothing compared to 250$ + +NTAP end Nov 2026 diff --git a/Finance/Tickers/index.md b/Finance/Tickers/index.md index e1419a2..6d63531 100644 --- a/Finance/Tickers/index.md +++ b/Finance/Tickers/index.md @@ -26,6 +26,8 @@ [[CRDO]] +[[CRMD]] + [[CSV]] [[CSX]] diff --git a/Finance/index.md b/Finance/index.md index f584e72..9ca3e56 100644 --- a/Finance/index.md +++ b/Finance/index.md @@ -6,7 +6,10 @@ [[Effect of GLP-1's on investment landscape]] # Dynamics and logic +ISM price paid leads inflation +Fed rate below inflation fuels growth (how?, easieer to finance yourself?) +Fed rate above inflation put downward pressure on growth probability = succesful outcomes / total outcomes @@ -26,7 +29,12 @@ If started positon half of max position can cut stp loss by half Start by analysing Volatility ATR of the stock to set initial hard stp loss and soft target +Jolts vs ADp vs NFP +more jobs = more consomption +every one who as a job is constently spending $ every M to fund their lifestyle +one person income is one person consomption +Labour mkt and consumer spending is both sides of the same coin Positive correlation between Nominal GDP growth rate & Nominal interest rates @@ -40,7 +48,10 @@ then assume the growth of the total TAM fo the business lets say 3% 8% growth is now the baseline, where you get the multiples, multiples the company should trade at 8% * 2 = 16 should be at 16x times multiples +When the price of money, interest rates, on Nominal and Real bais above or below where Nominal growth is, the surplus is one of the main driver of liquidity. +ex: If inflation running at 3% and Interest rates below that lvl or you have nominal growth at 5% and Nominal Rates below that level then that create more money in the system because comp[anies are operating on a nominal basis. They can finance themselves cheaper. +In past Dollar was backed by gold. Today secured by financial assets. Most important Financial assets are treasuries. Treasuries are secured by gov revenue. Gov revenues = Tax receipt. # COSTLY ERROR WTF WHY ARE THE CHART & BID NOT THE SAME AS MARKET PRICE IN ACCOUNT TAB ??? @@ -153,4 +164,3 @@ What not to do in EM https://www.wallstreetoasis.com/files/DEUTSCHEBANK-AGUIDETOTHEOIL%EF%BC%86GASINDUSTRY-130125.pdf - |
